A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Stopped Study prematurely terminated due to safety concerns leading to clinical hold

Conditions

• Infection, Human Immunodeficiency Virus

Interventions

• DRUG: GSK2838232 PIB (SDD)
• DRUG: GSK2838232 PIB (API)
• DRUG: Placebo
• DRUG: Ritonavir

Sponsor

GlaxoSmithKline